ED Flashcards

1
Q

analog of PGE1

Stimulation of adenyl cyclase causes increased production of cAMP which causes smooth-muscle relaxation of the arterial blood vessels to
and sinusoidal tissues in the corpora. This results in enhanced blood flow to and blood filling of the corpora

A

Alprostadil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

can cause weight gain, or exacerbate

hypertension, congestive heart failure, and edema

A

sodium retention a/e of testosterone replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

caused by inhibition of PDE11 in muscle

A

back and muscle pain PDE5 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Caution is recommended in airplane pilots

A

PDE5; rely on green and blue

lights for landing planes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

decreases intracellular calcium
concentrations to produce smooth-muscle relaxation in cells of the arteries
and cavernosal sinuses. Arterial blood flow to and blood filling of the corpora
are enhanced, and a penile erection results

A

cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

enhances the activity of
guanylate cyclase, which increases the conversion of cyclic guanosine
triphosphate to cGMP

A

Nitric oxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

enhances the production of nitric oxide by endothelial cells and
nonadrenergic-noncholinergic neurons

A

acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Female sexual partners may experience vaginal burning, itching, or
pain

A

Intraurethral alprostadil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

First line for ED

A

Sildenafil, tadalafil, vardenafil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is priapism managed?

A

In addition, needle aspiration

of sludged blood in the corpora or intracavernosal injection of α-adrenergic agonists (e.g., phenylephrine) can be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypotension
i. Increased sensitivity to light
ii. Blurred vision
iii. Loss of blue-green color discrimination
Back and muscle pain
Priapism
Sudden hearing loss usually on one side involving partial or complete
loss of usual hearing; reversible
Headache, facial flushing, rhinitis (due to vasodilation)

A

Sildenafil, tadalafil, vardenafil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

indicated in symptomatic

patients with primary or secondary hypogonadism

A

Testosterone replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intracavernosal
Cavernosal plaques or areas of fibrosis at injection sites
Burning discomfort or dull pain near the injection site or during the erection
Priapism

Intraurethral
Urethra injury leading to urethral stricture and difficulty voiding
Urethral pain
Female sexual partners may experience vaginal burning, itching, or pain
Priapism

A

Alprostadil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

intracavernosal - second line for ED

combination therapy - third line for ED

A

Alprostadil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nitrates (severe hypotension)

Contraindicated in patients at risk of
ophthalmologic problems

Caution in airplane pilots

A

Sildenafil, tadalafil, vardenafil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

patients with sickle cell disease or

lymphoproliferative disorders are at risk of what adverse effect of ED drugs?

A

Patients at risk of priapism

17
Q

PDE5 Inhibitors

decrease catabolism of cGMP

A

Sildenafil, tadalafil, vardenafil

18
Q

Priapism is rare especially with (1) and (2) because of their
shorter durations of action

A
  1. sildenafil and 2. vardenafil
19
Q

Contraind.
Prostate cancer
BPH

A

Testosterone replacement

20
Q

Rank order of PDE5 inhibitors: Back and muscle pain

A

Sildenafil = vardenafil > tadalafil

21
Q

Rank order of PDE5 inhibitors: Hypotension

A

Sildenafil = vardenafil > tadalafil

22
Q

Rank order of PDE5 inhibitors: Priapism

A

Tadalafil > sildenafil = vardenafil

23
Q

Rank order of PDE5 inhibitors: Visual adverse effects

A

Sildenafil > vardenafil > tadalafil

24
Q

resulting from the conversion of testosterone to estrogen

in peripheral tissues

A

gynecomastia

25
Q

Severe hypotension can occur when PDE5 inhibitors are used in patients
taking?

A

nitrates

26
Q

Sickle cell disease (risk of priapism)
Lymphoproliferative disorders (risk of priapism)
Thrombocytopenia
Anticoagulants

Patients with poor-quality injection technique (patients with psychiatric
disorders, obese patients, patients who are blind, and patients with
severe arthritis)

A

Alprostadil

27
Q
Sodium retention
Gynecomastia
Decreased HDL cholesterol levels
Polycythemia
Hepatotoxicity (oral)
contact dermatitis (topical)
A

Testosterone replacement

28
Q

Summarize ED treatment

A

PDE5 inhibitors or non pharmalogic
intracavernosal alprostadil injection therapy
combination nonpharm with intracavernosal, or intracavernosal with intraurethral
penile prosthesis

29
Q

The progression of an erect penis to a flaccid state results from the actions
of (1) on (2), which contracts vascular
smooth muscle to decrease arterial inflow to the corpora and contracts
sinusoidal tissue in the corpora

A

norepinephrine

α1-adrenergic receptors

30
Q

This correct symptoms of hypogonadism, which include malaise, loss of muscle strength, depressed mood, and decreased libido

stimulates androgen receptors in the CNS and is thought to be responsible for maintaining normal sexual drive

A

Testosterone replacement

31
Q

This results from the agent’s
inhibition of phosphodiesterase type 6 in the photoreceptor cells in
the retina

A

Loss of blue-green color discrimination (PDE5 inhibitors)

32
Q

how do nitrates cause severe hypotension when taken with pde5 inhibitor?

A

nitrates supply NO which increases activity of guanylyl cyclase which converts GTP to cGMP; the hypotensive effects of both drugs cause the issue